Axis Wealth Partners LLC purchased a new position in shares of UnitedHealth Group Incorporated (NYSE:UNH – Free Report) during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm purchased 1,608 shares of the healthcare conglomerate’s stock, valued at approximately $814,000.
Other institutional investors and hedge funds have also modified their holdings of the company. Wallace Capital Management Inc. grew its position in shares of UnitedHealth Group by 0.9% during the 3rd quarter. Wallace Capital Management Inc. now owns 2,119 shares of the healthcare conglomerate’s stock valued at $1,239,000 after acquiring an additional 19 shares during the period. Western Pacific Wealth Management LP raised its stake in shares of UnitedHealth Group by 2.2% during the 4th quarter. Western Pacific Wealth Management LP now owns 902 shares of the healthcare conglomerate’s stock worth $456,000 after buying an additional 19 shares during the period. Paragon Capital Management LLC grew its stake in UnitedHealth Group by 2.9% in the 3rd quarter. Paragon Capital Management LLC now owns 721 shares of the healthcare conglomerate’s stock valued at $422,000 after acquiring an additional 20 shares during the period. MCF Advisors LLC raised its position in UnitedHealth Group by 0.8% during the fourth quarter. MCF Advisors LLC now owns 2,578 shares of the healthcare conglomerate’s stock worth $1,304,000 after acquiring an additional 20 shares during the period. Finally, Axiom Financial Strategies LLC raised its position in shares of UnitedHealth Group by 3.6% during the 4th quarter. Axiom Financial Strategies LLC now owns 575 shares of the healthcare conglomerate’s stock worth $291,000 after purchasing an additional 20 shares during the last quarter. Institutional investors and hedge funds own 87.86% of the company’s stock.
Analysts Set New Price Targets
Several analysts recently commented on UNH shares. Truist Financial dropped their price target on UnitedHealth Group from $625.00 to $610.00 and set a “buy” rating for the company in a research report on Monday, January 6th. Piper Sandler decreased their price target on shares of UnitedHealth Group from $605.00 to $600.00 and set an “overweight” rating on the stock in a research note on Thursday, January 2nd. HSBC upgraded shares of UnitedHealth Group from a “hold” rating to a “buy” rating and set a $595.00 price objective for the company in a report on Friday, January 10th. KeyCorp reaffirmed an “overweight” rating and issued a $650.00 price target on shares of UnitedHealth Group in a report on Friday, January 17th. Finally, Wells Fargo & Company dropped their target price on UnitedHealth Group from $694.00 to $660.00 and set an “overweight” rating for the company in a report on Tuesday, January 28th. One investment analyst has rated the stock with a hold rating, twenty have assigned a buy rating and two have issued a strong buy rating to the stock. Based on data from MarketBeat, the company has an average rating of “Buy” and an average price target of $629.32.
Insider Buying and Selling
In related news, Director Timothy Patrick Flynn acquired 1,000 shares of the firm’s stock in a transaction that occurred on Friday, January 17th. The shares were acquired at an average price of $511.57 per share, with a total value of $511,570.00. Following the completion of the purchase, the director now directly owns 4,500 shares in the company, valued at approximately $2,302,065. The trade was a 28.57 % increase in their ownership of the stock. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Insiders own 0.33% of the company’s stock.
UnitedHealth Group Stock Performance
NYSE UNH opened at $493.35 on Friday. The company has a current ratio of 0.83, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74. UnitedHealth Group Incorporated has a 12-month low of $436.38 and a 12-month high of $630.73. The stock has a market capitalization of $451.28 billion, a price-to-earnings ratio of 31.83, a PEG ratio of 1.37 and a beta of 0.62. The business’s 50 day moving average is $513.78 and its two-hundred day moving average is $553.57.
UnitedHealth Group (NYSE:UNH – Get Free Report) last announced its quarterly earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $6.74 by $0.07. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The business had revenue of $100.81 billion during the quarter, compared to the consensus estimate of $101.60 billion. During the same quarter last year, the firm posted $5.83 EPS. The business’s revenue was up 6.8% compared to the same quarter last year. Research analysts expect that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.
UnitedHealth Group Dividend Announcement
The company also recently announced a quarterly dividend, which will be paid on Tuesday, March 18th. Shareholders of record on Monday, March 10th will be issued a $2.10 dividend. This represents a $8.40 annualized dividend and a yield of 1.70%. The ex-dividend date is Monday, March 10th. UnitedHealth Group’s dividend payout ratio (DPR) is 54.19%.
UnitedHealth Group Profile
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
Featured Stories
- Five stocks we like better than UnitedHealth Group
- Airline Stocks – Top Airline Stocks to Buy Now
- One Must-Buy Stock and One to Avoid as Tariffs Shake the Market
- Options Trading – Understanding Strike Price
- These 4 Tech ETFs Just Hit 50-Day Lows—Time to Buy?
- How to start investing in penny stocks
- 3 Stocks to Buy While Others Stay on the Sidelines
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.